The US Food & Drug Administration is moving ahead with plans to host virtual advisory committee meetings as the agency continues to respond to the need for social distancing during the COVID-19 crisis, Office of New Drug Director Peter Stein said in an interview with the Pink Sheet.
The decision to move ahead with virtual advisory committees will build on FDA’s increasing experience with online hosting of large...